Monopar Therapeutics Inc. (NASDAQ: MNPR) started the day on August 12, 2020, with a price decrease of -5.45% at $6.99. During the day, the stock rose to $14.40 and sunk to $6.90 before settling in for the price of $7.39 at the close. Taking a more long-term approach, MNPR posted a 52-week range of $4.94-$48.00.
Nevertheless, stock’s Earnings Per Share (EPS) this year is -30.90%. This publicly-traded company’s shares outstanding now amounts to $10.61 million, simultaneously with a float of $2.22 million. The organization now has a market capitalization sitting at $76.47 million. At the time of writing, stock’s 50-day Moving Average stood at $7.74.
Monopar Therapeutics Inc. (MNPR) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Monopar Therapeutics Inc.’s current insider ownership accounts for 2.10%, in contrast to 0.30% institutional ownership.
Monopar Therapeutics Inc. (MNPR) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 6/29/2020, the organization reported -$0.14 earnings per share (EPS) for the three months, lower than the consensus estimate (set at -$0.09) by -$0.05. This company achieved a return on equity of -43.23. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.3 per share during the current fiscal year.
Monopar Therapeutics Inc.’s EPS decrease for this current 12-month fiscal period is -30.90% and is forecasted to reach -1.71 in the upcoming year.
Monopar Therapeutics Inc. (NASDAQ: MNPR) Trading Performance Indicators
Let’s observe the current performance indicators for Monopar Therapeutics Inc. (MNPR). It’s Quick Ratio in the last reported quarter now stands at 28.70. The Stock has managed to achieve an average true range (ATR) of 1.04.
In the same vein, MNPR’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.38, a figure that is expected to reach -0.09 in the next quarter, and analysts are predicting that it will be -1.71 at the market close of one year from today.
Technical Analysis of Monopar Therapeutics Inc. (MNPR)
If we take a close look at the recent performances of Monopar Therapeutics Inc. (NASDAQ: MNPR), its last 5-days Average volume was 1.33 million that shows progress from its year to date volume of 56214.0. During the previous 9 days, stock’s Stochastic %D was recorded 22.43% While, its Average True Range was 1.37.
Raw Stochastic average of Monopar Therapeutics Inc. (MNPR) in the period of the previous 100 days is set at 11.26%, which indicates a major rise in contrast to 4.51% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 57.35% that was lower than 87.03% volatility it exhibited in the past 100-days period.